Patients included had to be older than 20 years of age and undergoing treatment for DM at the clinic. DM was defined as present if any of the following characteristics was observed: history of physician-diagnosed DM, use of medication for DM, fasting blood glucose concentration of at least 126 mg/dl, or non-fasting blood glucose concentration of at least 200 mg/dl. We excluded participants with a history of the following diseases: coronary heart disease; stroke (including transient ischemic attack); congestive heart failure; peripheral artery disease; arrhythmias, including atrial fibrillation and atrial flutter; neurodegenerative disease, including Parkinson disease; and malignancy. Coronary heart disease included a previous myocardial infarction (defined as a physician-diagnosed myocardial infarction or as a silent myocardial infarction as identified by electrocardiography [ECG] ) or a previous coronary revascularization procedure or coronary artery bypass surgery. Peripheral artery disease was defined as an ankle-brachial index 0.9 or a history of revascularization. Atrial fibrillation and flutter were also determined from the baseline ECG. The eligible patients were included in the study. This study was approved by the Ethics Committees of Yokohama City University Hospital, and informed consent was obtained from all subjects (UMIN Clinical Trials Registry: UMIN000009187).
Study Design
This was a cross-sectional study. Patient characteristics, including demographic data, anthropometric data, BP measurements, laboratory data profiles, medications prescribed, and medical problems, were obtained. Body mass index was calculated as weight (kg) divided by height squared (m 2 ). HT was defined as either a resting seated systolic BP (SBP) of at least 140 mmHg, or a diastolic BP (DBP) of at least 90 mmHg, or use of antihypertensive medications. DL was defined as serum concentrations of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, or triglycerides to be ≥ 140 mg/dl, 40 mg/ dl, and ≥ 150 mg/dl, respectively, or if the patient was already being treated with lipid-lowering agents.
CAVI and Ankle-brachial Index Measurements
CAVI and ankle-brachial index (ABI) were measured using a VaSera VS-1000 vascular screening system (Fukuda Denshi, Tokyo, Japan). The principal underlying CAVI has been described previously 8) . Cuffs were applied to bilateral upper arms and ankles, with the subjects lying in a supine position and holding their heads along the midline. ECG electrodes were placed on both wrists, and a microphone was placed over the sternum for the detection of heart markers for the incidence of CVD and CVD mortality.
Cardio-ankle vascular index (CAVI) is a new index of arterial stiffness that is designed to be essentially independent of blood pressure (BP). CAVI is adjusted for BP based on the stiffness parameter beta and therefore CAVI is reportedly less influenced by BP than baPWV is 8) . CAVI reflects even a slight-tomoderate extent of carotid atherosclerosis and can be used for the early detection of arteriosclerosis [9] [10] [11] . A recent study revealed that a high CAVI predicts CVD in obese patients 12, 13) , and a close relationship between arterial stiffness and the various stages of arteriosclerosis progression has been reported 14, 15) . Diabetes mellitus (DM), hypertension (HT), dyslipidemia (DL), and smoking are risk factors for CVDs such as stroke and coronary artery disease and are known to cause and accelerate arteriosclerosis 16, 17) . In arteriosclerotic risk factors, DM is a major risk factor for CVD 18) . In the evaluation of arteriosclerosis, arterial stiffness indexes such as PWV [19] [20] [21] and CAVI 22) are reported to increase in patients with DM compared with those in patients without DM.
Patients with orthostatic hypotension (OH) often have high arterial stiffness. OH is defined as a dysfunction in hemodynamic BP regulation during standing. In postural changes, successful rapid responses in the circulatory system are needed to maintain the cerebral flow when changing the posture to the upright position. These responses include appropriate changes in arterial and venous vessel diameters, cardiac output, and skeletal muscle pumps of the lower body 23) . In everyday clinical practice, the sit-to-stand test (STST) can be easily used to test postural BP changes for the detection of OH. It is a simple procedure and it is safe for elderly subjects.
In community-based, middle-aged, and elderly normotensive subjects, patients with OH assessed by STST had high baPWV 24) . In patients with DM who are likely to have cardiac autonomic neuropathy leading to OH, it is unclear if OH complications are a sign of significant progression in arterial stiffness.
Aim
We aimed to investigate whether CAVI varies between DM patients with and without OH using the STST.
Methods

Study Participants
From October 2012 to July 2015, we recruited patients who presented to the Kobayashi Medical Clinic in Yokohama, Japan for medical treatment.
that in the sitting position. HR was calculated as the average number of R-R intervals in 1 min. Power spectrum analysis was conducted using the MemCalc method described below; it is based on the variability of the 1-min R-R intervals. The analysis was repeated on a beat-to-beat basis and all results in a 1 min period were averaged and used as representative values.
Measurement of Autonomic Parameters
Beat-to-beat recording of HR was conducted with the 3-lead ECG in the sitting and upright positions. The majority of previous studies have used spectral techniques based on the fast Fourier transform (FFT). However, FFT is insufficient to estimate the precise power spectral density from short time series data. The MemCalc method 25) is a new technique for time series analysis. It is a combination of the maximum entropy method for spectral analysis and the non-linear least squares method for fitting analysis. This enabled us to achieve a reliable analysis of the low-frequency component (LF; 0.05-0.15 Hz) and the high-frequency component (HF; 0.15-0.4 Hz) over a minimum interval of 30 s. Time domain analysis and spectral analyses of HR variability using the MemCalc system were performed for each 1-min period during the standing test. HF was used as an index of parasympathetic activity, while LF was used as mixed indices of sympathetic and parasympathetic activity. LF/ HF was used as an index of sympathetic activity 26) .
sounds. The patients rested in this supine position for at least 5 min before monitoring was started. CAVI was calculated using the following formula: CAVI a{(2 / P) ln(Ps/Pd )PWV 2 } b, where PWV is pulse wave velocity from the origin of the aorta to the junction of the tibial artery with the femoral artery, Ps is the SBP, Pd is the diastolic blood pressure, P is Ps Pd, is blood density, and a and b are constants. The ABI was calculated as the ratio of the ankle SBP to the brachial SBP.
Measurement of Postural BP and Heart Rate (HR) Changes
BP, HR, and R-R interval measurements during the sitting and standing positions were performed using the Kiritsu Meijin autonomic reflex, orthostatic tolerance test instrument (Crosswell, Kanagawa, Japan). This device included a BP monitor (TM 2584: A&D Co. Ltd., Tokyo, Japan) and a HR monitor LRR-03 (GMS, Tokyo, Japan). Patients rested for 5 min in a seated position before the postural challenge. Patients assumed a seated position for 2 min, followed by an active standing position for 2 min. BP was evaluated 1 min before standing (sitting position), immediately after standing (initial upright position), and 1 min after standing (late upright position). OH was defined as a decline in SBP of at least 20 mmHg and/ or a decline in DBP of at least 10 mmHg at any of the 2 (initial and late) upright positions compared with 
Statistical Analysis
Values are expressed as the mean standard deviation, frequency, and percentages. Student's t -test was used to compare continuous variables and the 2 -test and Fisher's exact test were used to test for differences between categorical variables. Spearman's correlation coefficient was calculated to evaluate the relationship among parameters. HF and LF indexes were log-transformed (logHF and logLF) prior to analysis due to skewness. All statistical analyses were carried out using SPSS for Windows, version 17.0 (SPSS Inc., Chicago, IL, USA), and a p-value of less than 0.05 was considered to indicate statistical significance.
Results
In total, 159 patients with DM were evaluated. The average SBP in the sitting position, initial upright position, and late upright position was 138.3 15.9 mmHg, 129.7 16.2 mmHg, and 136.1 17.0 mmHg, respectively. The average DBP in the sitting position, initial upright position, and late upright position was 83.1 9.1 mmHg, 80.2 9.4 mmHg, and 82.3 9.8 mmHg, respectively. OH was diagnosed in 42 patients (26.4%). The clinical characteristics of patients with DM are shown according to the presence or absence of OH in Table 1 . Patients with OH had significantly higher SBP, DBP, HR, and serum creatinine levels than those without OH. Table 2 shows the BP and HR measurements during the postural changes.
As shown in Fig. 1a , DM patients with OH had Table 3 . DM patients with OH showed a significantly lower logHF change in the late upright position than those without OH. Concerning cardiac autonomic activity and CAVI, there were significant inverse correlations between CAVI and both logLF and logHF in the sitting position, logLF in the initial upright position, and both logLF and logHF in the late upright position ( Table 4) . significantly higher CAVI (9.36 1.15 versus 8.89 1.18, p 0.026) than those without OH had. There were no differences in ABI measurements between DM patients with and without OH (1.14 0.07 versus 1.13 0.07, p 0.408, Fig. 1b) .
As shown in Fig. 2a and 2b , there was a significant negative correlation between CAVI and SBP change in the initial upright position (R 0.347, p 0.001), whereas there was no significant correlation between CAVI and SBP change in the late upright position (R 0.069, p 0.389).
As shown in Fig. 2c and 2d , there was a significant negative correlation between CAVI and DBP 
Discussion
In the present study, patients with DM underwent the measurement of arterial stiffness by CAVI, and measurements of BP and cardiac autonomic activity during the STST. DM patients with OH showed more advanced arterial stiffness than DM patients without OH. Postural drop in SBP during the simple STST is independently associated with CAVI level in patients with DM. Our study suggests that a postural drop in BP during the simple STST is clinically effective in determining arterial stiffness progression in
Stepwise multivariate regression analysis revealed that age, SBP change in the initial upright position, and logLF in the initial upright position were independent determinants of CAVI (R 2 0.384, Table 5 ). When logHF in the initial upright position and LF/ HF in the initial upright position, instead of logLF in the initial upright position, were entered one-by-one in the multivariate regression analysis, SBP change in the initial upright position remained a significant determinant (p 0.010, p 0.010, respectively). Patients with DM are at a high risk of severe arterial stiffness and cardiac autonomic neuropathy 20) . Arterial stiffness 6) and cardiac autonomic dysfunction 27) in patients with DM are known to significantly affect prognosis. Cardiac autonomic neuropathy can be evaluated by spectral analysis of HR variability 28) . Our study showed that an orthostatic BP drop was independently related to CAVI after adjustment for HR variability parameters. The results implied that patients with DM.
Arterial stiffness is caused and affected by many clinical factors including aging, DM, DL, HT, smoking, and inflammation 13) . A drop in SBP during the STST was independently associated with arterial stiffness after adjustment for related factors; this adjustment showed that the association was not influenced by confounding factors. A BP drop during the STST necessitates a careful evaluation of CVD risk. especially in high-risk populations such as the elderly. However, the load of the STST is generally considered to be less than that of the supine-to-stand test. Therefore, OH detected by STST may be a more severe pathological condition. If OH is detected by STST, the patient may need further examination for arteriosclerosis and the appropriate medical management. This study has limitations that should be taken into account when interpreting the results. First, the cross-sectional design may have limited our ability to infer a causal relationship between arterial stiffness and OH in patients with DM. Second, in the protocol for OH detection in this study, BP change after standing was traced for a relatively short period. Therefore, any OH-associated BP drops that occurred outside of this tracing period would not have been detected. However, patients with OH diagnosed by the STST showed increased arterial stiffness, suggesting that the STST has clinical implications for the management of arteriosclerosis.
Conclusion
The results of this study using CAVI measurements and the STST method indicate that patients with DM that experience large BP drops have high arterial stiffness. In patients with DM, a postural BP drop from sitting to standing may be partially attributed to arterial stiffness. A large postural drop in BP during the STST needs careful examination of advanced arterial stiffness in patients with DM. Shoko Niida, and Mr. Taiki Matsubayashi in this study.
arterial stiffness is involved in the postural BP regulation in patients with DM independent of cardiac autonomic activity. Our finding is consistent with that reported in non-DM populations 24, 29) , and supports the contribution of arterial stiffness to OH development, even in patients with DM.
Our analysis showed the inverse relationships between LF components and CAVI. The LF component is considered to represent baroreceptor activity 30) . Baroreceptors are located inside the arterial wall and are triggered by stretch. Arterial stiffness may hamper stretch, reduce baroreceptor sensitivity, and contribute to a drop in postural BP 31) . Our results infer that arterial stiffness may affect the function of baroreceptors in the carotid artery and aorta, similar to previous reports 32, 33) . An initial BP drop during the STST was associated with CAVI levels; a late BP drop was not. The pathophysiology of the initial BP drop is believed to be a temporal mismatch between cardiac output and vascular resistance and does not necessarily result in classic OH 34) . Inadequate cardiac output during postural change may be due to arterial stiffness because this stiffness may impair the buffering effect of the large artery during BP fluctuations 35) . Our results suggested that arterial stiffness is likely to result in an initial orthostatic BP drop and that this drop may be a more sensitive marker for arteriosclerosis than subsequent postural BP drops.
Increasing evidence has shown that arterial stiffness is a strong predictor for morbidity 12) and mortality 6, 7) . The evaluation of arterial stiffness is necessary to provide adequate care for patients at risk for CVD. However, dedicated equipment and space and elaborate efforts are needed to measure arterial stiffness. The STST, a simple and easily performed method, may have many advantages for evaluating the progress of arterial stiffness in routine clinical practice.
STST load represents a physiologic challenge that usually occurs in daily life 36) . Detection of OH by STST may be necessary to assess the risk of falling, Variables used in the models were age, gender, body mass index, SBP, heart rate, triglyceride, HDL cholesterol, LDL cholesterol, fasting glucose, hemoglobin A1c, creatinine, logLF in initial upright position, and SBP change in initial upright position. Adjusted R 2 0.384, F value 16.183, P 0.001. Abbreviations: B, partial regression coefficient; , standardized partial regression coefficient; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure.
